{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:56:27Z","timestamp":1762430187100,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":5668,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1111\/j.1538-7836.2007.02522.x","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T11:32:24Z","timestamp":1180179144000},"page":"1227-1236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer"],"prefix":"10.1016","volume":"5","author":[{"given":"E.F.","family":"COHN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"ZHUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"KELLY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"CHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2003-37972","article-title":"Treatment of the bleeding inhibitor patient","volume":"29","author":"Astermark","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.2004.05168.x","article-title":"Inhibitors in congenital coagulation disorders","volume":"127","author":"Key","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2516.1998.440574.x","article-title":"Management of haemophilia B patients with inhibitors and anaphylaxis","volume":"4","author":"Warrier","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.gt.3300548","article-title":"Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia","volume":"5","author":"Monahan","year":"1998","journal-title":"Gene Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0030","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood.V97.12.3733","article-title":"Factors influencing the development of an anti\u2010factor IX (FIX) immune response following administration of adeno\u2010associated virus\u2010FIX","volume":"97","author":"Ge","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/mthe.2001.0441","article-title":"Risk and prevention of anti\u2010factor IX formation in AAV\u2010mediated gene transfer in the context of a large deletion of F9","volume":"4","author":"Fields","year":"2001","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0040","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood-2002-10-3050","article-title":"Neonatal or hepatocyte growth factor\u2010potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B","volume":"101","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0045","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1073\/pnas.92.5.1401","article-title":"Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long\u2010term expression","volume":"92","author":"Dai","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0055","first-page":"305","article-title":"AAV vectors for hemophilia B gene therapy","volume":"71","author":"Chao","year":"2004","journal-title":"Mt Sinai J Med"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0060","first-page":"119","article-title":"Adeno\u2010associated virus as a gene therapy vector: vector development, production and clinical applications","volume":"99","author":"Grieger","year":"2005","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0065","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV\u2010Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0070","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/sj.gt.3301024","article-title":"Persistent expression of canine factor IX in hemophilia B canines","volume":"6","author":"Chao","year":"1999","journal-title":"Gene Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/mthe.2000.0219","article-title":"Several log increase in therapeutic transgene delivery by distinct adeno\u2010associated viral serotype vectors","volume":"2","author":"Chao","year":"2000","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/mthe.2001.0449","article-title":"Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors","volume":"4","author":"Chao","year":"2001","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0085","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross\u2010packaging of a single adeno\u2010associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J Virol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0090","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno\u2010associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2003-05-1446","article-title":"Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno\u2010associated viral vector serotype 1","volume":"103","author":"Arruda","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/1043034041648453","article-title":"Therapeutic levels of factor IX expression using a muscle\u2010specific promoter and adeno\u2010associated virus serotype 1 vector","volume":"15","author":"Liu","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/mthe.2001.0442","article-title":"Muscle\u2010directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation","volume":"4","author":"Herzog","year":"2001","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0110","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","article-title":"A coagulation factor IX\u2010deficient mouse model for human hemophilia B","volume":"90","author":"Lin","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1988.tb04234.x","article-title":"IgG subclass identification of inhibitors to factor IX in haemophilia B patients","volume":"68","author":"Orstavik","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0049-3848(96)00136-3","article-title":"Measurement of anti\u2010factor IX IgG subclasses in haemophilia B patients who developed inhibitors with episodes of allergic reactions to factor IX concentrates","volume":"83","author":"Sawamoto","year":"1996","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0125","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.147.4.1383","article-title":"IgG subclass distribution of primary and secondary immune responses concomitant with viral infection","volume":"147","author":"Coutelier","year":"1991","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J Exp Med"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0135","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1084\/jem.168.6.2373","article-title":"Virally induced modulation of murine IgG antibody subclasses","volume":"168","author":"Coutelier","year":"1988","journal-title":"J Exp Med"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri981","article-title":"Hepatic T cells and liver tolerance","volume":"3","author":"Crispe","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0145","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV\u2010mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/clim.1999.4724","article-title":"Induction of immunity to antigens expressed by recombinant adeno\u2010associated virus depends on the route of administration","volume":"92","author":"Brockstedt","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JVI.75.1.269-277.2001","article-title":"Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors","volume":"75","author":"Sarukhan","year":"2001","journal-title":"J Virol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0160","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1128\/JVI.73.10.8549-8558.1999","article-title":"Latent adeno\u2010associated virus infection elicits humoral but not cell\u2010mediated immune responses in a nonhuman primate model","volume":"73","author":"Hernandez","year":"1999","journal-title":"J Virol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0165","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1089\/104303402760128513","article-title":"Influence of vector dose on factor IX\u2010specific T and B cell responses in muscle\u2010directed gene therapy","volume":"13","author":"Herzog","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.gt.3302881","article-title":"Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice","volume":"14","author":"Zhang","year":"2007","journal-title":"Gene Ther"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2516.1999.t01-1-00303.x","article-title":"Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk","volume":"5","author":"Thorland","year":"1999","journal-title":"Haemophilia"},{"issue":"Pt 9","key":"10.1111\/j.1538-7836.2007.02522.x_bb0180","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1099\/0022-1317-70-9-2439","article-title":"The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A\u2010purified subclass antibodies","volume":"70","author":"Hocart","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0185","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1098\/rspb.1964.0093","article-title":"Induction of Immunological Paralysis in Two Zones of Dosage","volume":"161","author":"Mitchison","year":"1964","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0190","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.91.14.6688","article-title":"Induction of anergy or active suppression following oral tolerance is determined by antigen dosage","volume":"91","author":"Friedman","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2007.02522.x_bb0195","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood-2001-11-0067","article-title":"Dangerous liaisons: the role of \u201cdanger\u201d signals in the immune response to gene therapy","volume":"100","author":"Brown","year":"2002","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02522.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622102047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622102047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02522.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:41:17Z","timestamp":1761532877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622102047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1538783622102047"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02522.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02522.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}